Literature DB >> 15765246

Novel G335V mutation in the tau gene associated with early onset familial frontotemporal dementia.

Manuela Neumann1, Silvia Diekmann, Uwe Bertsch, Ben Vanmassenhove, Bernhard Bogerts, Hans A Kretzschmar.   

Abstract

Mutations in the tau gene cause familial frontotemporal dementia and parkinsonism linked to chromosome 17. Here we describe a novel missense mutation in exon 12 of the tau gene, G335V, in a German family with frontotemporal dementia of early age at onset, in the third decade of life. Functional analysis of recombinant tau protein with the G335V mutation showed a dramatically reduced ability to promote microtubule assembly and a more rapid and accelerated tau filament formation, suggesting that the primary effect of the mutation might be the provision of a pool of unbound tau making it available for aberrant tau aggregation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15765246     DOI: 10.1007/s10048-005-0210-y

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  27 in total

1.  Pick's disease associated with the novel Tau gene mutation K369I.

Authors:  M Neumann; W Schulz-Schaeffer; R A Crowther; M J Smith; M G Spillantini; M Goedert; H A Kretzschmar
Journal:  Ann Neurol       Date:  2001-10       Impact factor: 10.422

2.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.

Authors:  M Hong; V Zhukareva; V Vogelsberg-Ragaglia; Z Wszolek; L Reed; B I Miller; D H Geschwind; T D Bird; D McKeel; A Goate; J C Morris; K C Wilhelmsen; G D Schellenberg; J Q Trojanowski; V M Lee
Journal:  Science       Date:  1998-12-04       Impact factor: 47.728

3.  The microtubule binding domain of tau protein.

Authors:  G Lee; R L Neve; K S Kosik
Journal:  Neuron       Date:  1989-06       Impact factor: 17.173

4.  Accelerated filament formation from tau protein with specific FTDP-17 missense mutations.

Authors:  P Nacharaju; J Lewis; C Easson; S Yen; J Hackett; M Hutton; S H Yen
Journal:  FEBS Lett       Date:  1999-03-26       Impact factor: 4.124

5.  Identification and characterization of the Drosophila tau homolog.

Authors:  G Heidary; M E Fortini
Journal:  Mech Dev       Date:  2001-10       Impact factor: 1.882

6.  5' splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10.

Authors:  A Grover; H Houlden; M Baker; J Adamson; J Lewis; G Prihar; S Pickering-Brown; K Duff; M Hutton
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

7.  Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly.

Authors:  M Hasegawa; M J Smith; M Goedert
Journal:  FEBS Lett       Date:  1998-10-23       Impact factor: 4.124

8.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.

Authors:  M G Spillantini; J R Murrell; M Goedert; M R Farlow; A Klug; B Ghetti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

9.  Frontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau gene.

Authors:  S M Pickering-Brown; M Baker; T Nonaka; K Ikeda; S Sharma; J Mackenzie; S A Simpson; J W Moore; J S Snowden; R de Silva; T Revesz; M Hasegawa; M Hutton; D M A Mann
Journal:  Brain       Date:  2004-03-26       Impact factor: 13.501

10.  Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

Authors:  M Goedert; M G Spillantini; M C Potier; J Ulrich; R A Crowther
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  9 in total

Review 1.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

2.  Unlocking truths of γ-secretase in Alzheimer's disease: what is the translational potential?

Authors:  Michael S Wolfe
Journal:  Future Neurol       Date:  2014

Review 3.  Tau and MAPT genetics in tauopathies and synucleinopathies.

Authors:  Etienne Leveille; Owen A Ross; Ziv Gan-Or
Journal:  Parkinsonism Relat Disord       Date:  2021-09-14       Impact factor: 4.402

4.  Impaired tau-microtubule interactions are prevalent among pathogenic tau variants arising from missense mutations.

Authors:  Yuxing Xia; Zachary A Sorrentino; Justin D Kim; Kevin H Strang; Cara J Riffe; Benoit I Giasson
Journal:  J Biol Chem       Date:  2019-10-24       Impact factor: 5.157

Review 5.  Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging.

Authors:  B Ghetti; A L Oblak; B F Boeve; K A Johnson; B C Dickerson; M Goedert
Journal:  Neuropathol Appl Neurobiol       Date:  2015-02       Impact factor: 8.090

Review 6.  A network of RNA and protein interactions in Fronto Temporal Dementia.

Authors:  Francesca Fontana; Kavitha Siva; Michela A Denti
Journal:  Front Mol Neurosci       Date:  2015-03-19       Impact factor: 5.639

7.  de novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia.

Authors:  Kunie Ando; Lorenzo Ferlini; Valérie Suain; Zehra Yilmaz; Salwa Mansour; Isabelle Le Ber; Cécile Bouchard; Karelle Leroy; Alexandra Durr; Fabienne Clot; Marie Sarazin; Jean-Christophe Bier; Jean-Pierre Brion
Journal:  Acta Neuropathol Commun       Date:  2020-06-29       Impact factor: 7.801

Review 8.  Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey.

Authors:  Paulo J da Costa; Malika Hamdane; Luc Buée; Franck Martin
Journal:  Biomedicines       Date:  2022-01-23

Review 9.  The role of tau in neurodegenerative diseases and its potential as a therapeutic target.

Authors:  Michael S Wolfe
Journal:  Scientifica (Cairo)       Date:  2012-12-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.